Tegafur–Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer

Tegafur–Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer

This study aimed to explore the safety and efficacy of neoadjuvant SCRT and tegafur–uracil/leucovorin plus oxaliplatin (TEGAFOX) for LARC in comparison to those of the modified 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX-6) regimen. We retrospectively evaluated 15 and 22 patients with LARC...

Full description

Bibliographic Details
Main Authors: Chun-Kai Liao, Ya-Ting Kuo, Yih-Jong Chern, Yu-Jen Hsu, Yueh-Chen Lin, Yen-Lin Yu, Pao-Shiu Hsieh, Jy-Ming Chiang, Chien-Yuh Yeh, Jeng-Fu You
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
short-course radiotherapy
locally advanced rectal cancer
consolidation chemotherapy
neoadjuvant rectal score
TEGAFOX
FOLFOX
Online Access:https://www.mdpi.com/2077-0383/11/10/2920

Internet

https://www.mdpi.com/2077-0383/11/10/2920

Similar Items